Radiopharmaceutical Market: Market and Growth Analysis 2024
The global market for radiopharmaceuticals is poised for steady growth in the coming years, driven primarily by the rising use of radioisotopes for the treatment of various diseases, such as cancer, bone palliation, neurological disorders, and cardiovascular diseases. Around 35 million patients undergo treatment procedures for these diseases each year and this will continue to boost the demand for radiopharmaceuticals.
According to the Nuclear Energy Institute, radioisotopes are essential for biomedical research in order to cure AIDS, cancer, and Alzheimer’s disease. The World Nuclear Association states that around 10,000 hospitals across the world use radioisotopes in medicines and 90% of this is dedicated toward disease diagnosis.
The global radiopharmaceutical market was valued at US$4.7 bn in 2015 and is estimated to reach US$7.4 bn by 2024, expanding at a CAGR of 5.3% from 2016 to 2024.
Growing Incidence of Cancer Driving Demand for Most Radioisotopes
Based on radioisotope, the technetium-99 segment led the global radiopharmaceuticals market, accounting for a share of 50.3% in 2015. This can be attributed to the high availability of technetium-99 from molybdenum-99, which is generated through the decay of uranium radioactive raw material inside the sources.
The 18F radioisotope segment is expected to gain market share during the forecast period due to the increase in demand for cyclotron-based radioisotopes for nuclear medicine and the advancement of technological systems such as PET and SPECT. The demand for other radioisotopes such as lutetium-177, rubidium-87, and gallium-62 is also high due to the rising demand for radioisotopes for cancer treatment, the surge in the prevalence of cardiovascular diseases, and the detection of other infectious diseases. Based on application, oncology took the lead owing to the growing use of various radioisotopes in the treatment of different cancers.
Radiopharmaceutical products are used by various end users such as hospitals, ambulatory surgical centers, and diagnostic centers. Hospitals formed the leading segment of the market in terms of revenue in 2015 due to the growing usage of radiopharmaceutical. This can be attributed to technological advancements in various systems to cure cancer patients and the rise in favorable government reimbursement policies to help patients recover their costs and provide precaution against biohazards. The ambulatory surgical centers and diagnostic centers segments are expected to gain market share by 2024 due to the introduction of advanced imaging technologies such as SPECT and PET.
This exhaustive report includes a 360° view of the Radiopharmaceutical Market. Browse through this 246-page report to know what factors will shape the market during the period 2016-2024
Developing Regions to Witness Steady Growth despite Small Share in Global Market
The global radiopharmaceuticals market has been segmented into North America, Latin America, Asia Pacific, Europe, and the Middle East and Africa. North America led the radiopharmaceuticals market in 2015 in terms of revenue, with the U.S. emerging as the most prominent contributor to the radiopharmaceuticals market in North America. This can be attributed to the existence of several large nuclear reactors such as NRU, which accounts for a 30% to 40% share in the Mo-99 supply for the global production of nuclear medicine.
Europe is also expected to account for a significant share by 2024 due to the increase in the number of cyclotron installations for the production of radioisotopes used in the treatment of cancer and other diseases.
The Middle East and Africa is projected to account for a small share in the global market by 2024. However, growth in this market is likely to be attributed to the introduction of cyclotrons by the IBA Group and the setting up of new nuclear reactors such as ETRR-2 in South Africa for the production of radioisotopes.
Latin America is estimated to account for a meager share by the end of the forecast period. However, it continues to be driven by the increase in domestic collaborations with foreign radiopharmaceutical companies and major suppliers of radioactive raw materials and the establishment of hospitals and ambulatory surgical centers for cancer patients.
Prominent players operating in the radiopharmaceutical market include Advanced Accelerator Applications (AAA), Eckert & Ziegler, GE Healthcare, IBA Radiopharma Solutions, Lantheus Holdings, Inc., Mallinckrodt plc., Nordion, Inc., Siemens Healthineers, and Positron Corporation.
Request a brochure of this report to know what opportunities will emerge in the rapidly evolving Radiopharmaceutical Market during 2016- 2024
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Radiopharmaceutical Market: Market and Growth Analysis 2024 here
News-ID: 675224 • Views: 352
More Releases from Transparency Market Research - Pharmaceutical
Neurovascular Devices Market Business Opportunities and Growth Challenges Report
Global Neurovascular Devices Market: Overview The global population is aging rapidly. According to WHO, the chances of health risks are greater in geriatric people than the young generation. Old age is considered to be one of the biggest risk factors that are responsible for developing various diseases such as cardiovascular and neurological conditions. It is because of these factors, the global neurovascular devices market is experiencing robust growth in the
Pneumococcal Vaccines Market anticipated expand at a CAGR of 3.3% from 2018 to 2 …
Transparency Market Research (TMR) has published a new report titled, “Pneumococcal Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global pneumococcal vaccines market was valued at US$ 7,247.6 Mn in 2017 and is anticipated expand at a CAGR of 3.3% from 2018 to 2026. Increase in patient pool, growth of the pharmaceutical industry, government initiatives to increase vaccination programs, rise
Swab and Viral Transport Medium Market projected to expand at a CAGR of ~3% from …
Swab and Viral Transport Medium Market: Introduction Transparency Market Research has published a new report titled, ‘Global Swab and Viral Transport Medium Market ’. According to the report, the global swab and viral transport medium market was valued at US$ 0.9 Bn in 2019 and is projected to expand at a CAGR of ~3% from 2020 to 2030. Viral transport medium (VTM) enables safe transfer of viruses, chlamydia, and mycoplasma for
Radiofrequency Ablation Devices Market by Product, Geography and Forecast to 202 …
Transparency Market Research (TMR) has published a new report titled, 'Radiofrequency Ablation Devices for Pain Management Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027'. According to the report, the global radiofrequency ablation devices for pain management market was valued at US$ 543.0 Mn in 2018 and is projected to expand at a CAGR of above 11.0% from 2019 to 2027. Overview Radiofrequency ablation is a minimally invasive surgical
More Releases for Radiopharma
Automated Radiosynthesis Modules Market 2019 | Global Forecast 2025 | Top Key Pl …
As per the latest research study published by Up Market Research, “Global Automated Radiosynthesis Modules Market” is estimated to grow at a healthy CAGR % in the coming years. The research report showcases qualitative and quantitative estimations by the industry analysts. The report documents first-hand data, post verification from the industry experts along with each industry manufacturers by the market valuation. Automated Radiosynthesis Modules Market report also gives an extensive
Global Radiopharmaceutical Market 2019 Advancements – Advanced Accelerator App …
Researchmoz added Most up-to-date research on "Radiopharmaceutical Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2024" to its huge collection of research reports. This report on the radiopharmaceutical market analyzes the current and future scenario of the global market. Increase in incidence of various diseases, development of new sources for radioisotope production, and rise in demand for nuclear medicine are boosting the radiopharmaceutical market. Increase in
Radiopharmaceuticals Market to 2016-2026: Advanced Accelerator Applications (Fra …
Researchmoz added Most up-to-date research on "Radiopharmaceuticals Market: Will Japan (Expected to Register an Attractive Growth Rate Throughout the Forecast Period) Beat Current Market Leader North America? - Global Industry Analysis and Opportunity Assessment, 2016-2026" to its huge collection of research reports. North America is anticipated to be the most attractive regional market in the global radiopharmaceuticals market North America accounted for more than 40% market share in the global radiopharmaceuticals market
Radiopharmaceuticals Market Competitive Scenario of Leading Key Players 2016 and …
Presence of radiopharmaceuticals in cancer medications has increased as research institutes have derived ways in which radioisotopes can impede the maturation of malignant tumour, cells and tissues. Increasing significance of radiotracers in therapeutic care of cancer and cardiovascular diseases has also impacted the growth in demand for radiopharmaceuticals. To know key findings Request Sample Report @: https://www.futuremarketinsights.com/reports/sample/rep-gb-1992 In a recent report published by Future Market Insights, the global radiopharmaceuticals revenues in 2016 reached
Automated Radiosynthesis Modules Market – Product Diversification 2025 | IBA R …
Global Automated Radiosynthesis Modules Market: Snapshot The global automated radiosynthesis modules market is forecasted to be a million-dollar opportunity for industry participants expected to be encouraged by a colossal demand in the recent years. End users of automated radiosynthesis modules could ensure an improved performance in their therapy monitoring and diagnostic activities. With the help of these modules, end users could also gain a wide scope for the customization of radiotracers.
Exclusive Nuclear Medicine Radiopharmaceuticals Market Research 2018-2023 Analys …
UpMarketResearch offers a latest published report on “Global Nuclear Medicine Radiopharmaceuticals Market Analysis and Forecast 2018-2023” delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 148 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Get FREE Exclusive PDF Sample Copy@ https://www.upmarketresearch.com/home/requested_sample/5139 Nuclear Medicine Radiopharmaceuticals Industry research report delivers a close watch on